IGFBP3 and systemic sclerosis: Our findings suggest that expressing IGFBP-5, and to a lesser extent IGFBP-3, in normal skin explants results in increased dermal thickness and increased collagen bundle thickness, thus recapitulating the dermal fibrosis seen in patients with SSc.